Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus

Disease Markers

Volumn 27, Issue 5, 2009, Pages 239-252

  Satoh, Jun Ichi ^a   Tabunoki, Hiroko ^a   Arima, Kunimasa ^b  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Alzheimer disease; CREB; Granulovacuolar degeneration; Keymolnet; Molecular network; Systems biology

Indexed keywords

BIOLOGICAL MARKER; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DEREGULATION; DISEASE MARKER; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MOLECULAR INTERACTION; NERVE CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION;

EID: 77249122985     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/618619     Document Type: Article

References (53)

1. A. Serretti, P. Olgiati and D. De Ronchi, Genetics of Alzheimer's disease. A rapidly evolving field, J Alzheimers Dis 12 (2007), 73-92.
2. S.F. Kingsmore, I.E. Lindquist, J. Mudge, D.D. Gessler and W.D. Beavis, Genome-wide association studies: progress and potential for drug discovery and development, Nat Rev Drug Discov 7 (2008), 221-230.
3. S.D. Ginsberg, S.E. Hemby, V.M. Lee, J.H. Eberwine and J.Q. Trojanowski, Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons, Ann Neurol 48 (2000), 77-87.
4. V. Colangelo, J. Schurr, M.J. Ball, R.P. Pelaez, N.G. Bazan and W.J. Lukiw, Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and proinflammatory signaling, J Neurosci Res 70 (2002), 462-473.
5. P. Katsel, C. Li and V. Haroutunian, Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochem Res 32 (2007), 845-856.
6. C. Williams, R. Mehrian Shai, Y. Wu, Y.H. Hsu, T. Sitzer, B. Spann, C. McCleary, Y. Mo and C.A. Miller, Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease, PLoS ONE 4 (2009), e4936.
7. K. Oda, Y. Matsuoka, A. Funahashi and H. Kitano, A comprehensive pathway map of epidermal growth factor receptor signaling, Mol Syst Biol 1 (2005), 2005.0010.
8. F. Noorbakhsh, C.M. Overall and C. Power, Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology, Trends Neurosci 32 (2009), 88-100.
9. R. Albert, H. Jeong and A.L. Barabasi, Error and attack tolerance of complex networks, Nature 406 (2000), 378-382.
10. E.M. Blalock, J.W. Geddes, K.C. Chen, N.M. Porter, W.R. Markesbery and P.W. Landfield, Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses, Proc Natl Acad Sci USA 101 (2004), 2173-2178.
11. J.A. Miller, M.C. Oldham and D.H. Geschwind, A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging, J Neurosci 28 (2008), 1410-1420.
12. H. Sato, S. Ishida, K. Toda, R. Matsuda, Y. Hayashi, M. Shigetaka, M. Fukuda, Y. Wakamatsu and A. Itai, New approaches to mechanism analysis for drug discovery using DNA microarray data combined with KeyMolnet, Curr Drug Discov Technol 2 (2005) 89-98.
13. D.W. Huang, B.T. Sherman and R.A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat Protoc 4 (2009), 44-57.
14. E.I. Boyle, S.Weng, J. Gollub, H. Jin, D. Botstein, J.M. Cherry and G. Sherlock, GO: TermFinder - open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes, Bioinformatics 20 (2004), 3710-3715.
15. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle and L. Berg, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology 41 (1991), 479-486.
16. H. Braak, I. Alafuzoff, T. Arzberger, H. Kretzschmar and K. Del Tredici, Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry, Acta Neuropathol 112 (2006), 389-404.
17. T. Misawa, K. Arima, H. Mizusawa and J. Satoh, Close association of water channel AQP1 with amyloid-βdeposition in Alzheimer disease brains, Acta Neuropathol 116 (2008), 247-260.
18. B. Mayr and M. Montminy, Transcriptional regulation by the phosphorylation-dependent factor CREB, Nat Rev Mol Cell Biol 2 (2001), 599-609.
19. B.E. Lonze and D.D. Ginty, Function and regulation of CREB family transcription factors in the nervous system, Neuron 35 (2002), 605-623.
20. J. Satoh, Z. Illes, A. Peterfalvi, H. Tabunoki, C. Rozsa and T. Yamamura, Aberrant transcriptional regulatory network in T cells of multiple sclerosis, Neurosci Lett 422 (2007), 30-33.
21. J. Satoh, T. Misawa, H. Tabunoki and T. Yamamura, Molecular network analysis of T-cell transcriptome suggests aberrant regulation of gene expression by NF-κB as a biomarker for relapse of multiple sclerosis, Dis Markers 25 (2008), 27-35.
22. X. Zhang, D.T. Odom, S.H. Koo, M.D. Conkright, G. Canettieri, J. Best, H. Chen, R. Jenner, E. Herbolsheimer, E. Jacobsen, S. Kadam, J.R. Ecker, B. Emerson, J.B. Hogenesch, T. Unterman, R.A.Young and M. Montminy, Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues, Proc Natl Acad Sci USA 102 (2005), 4459-4464.
23. H. Viola, M. Furman, L.A. Izquierdo, M. Alonso, D.M. Barros, M.M. de Souza, I. Izquierdo and J.H. Medina, Phosphorylated cAMP response element-binding protein as a molecular marker of memory processing in rat hippocampus: effect of novelty, J Neurosci 20 (2000), RC112.
24. M. Yamamoto-Sasaki, H. Ozawa, T. Saito, M. Rösler and P. Riederer, Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type, Brain Res 824 (1999), 300-303.
25. G.S. Griesbach, R.L. Sutton, D.A. Hovda, Z. Ying and F. Gomez-Pinilla, Controlled contusion injury alters molecular systems associated with cognitive performance, J Neurosci Res 87 (2009), 795-805.
26. B. Gong, O.V. Vitolo, F. Trinchese, S. Liu, M. Shelanski and O. Arancio, Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment, J Clin Invest 114 (2004), 1624-1634.
27. Z. Liang, F. Liu, I. Grundke-Iqbal, K. Iqbal and C.X. Gong, Down-regulation of cAMP-dependent protein kinase by overactivated calpain in Alzheimer disease brain, J Neurochem 103 (2007), 2462-2470.
28. D.N. Arvanitis, A. Ducatenzeiler, J.N. Ou, E. Grodstein, S.D. Andrews, S.R. Tendulkar, A. Ribeiro-da-Silva, M. Szyf and A.C. Cuello, High intracellular concentrations of amyloid-βblock nuclear translocation of phosphorylated CREB, J Neurochem 103 (2007), 216-228.
29. O.V. Vitolo, A. Sant'Angelo, V. Costanzo, F. Battaglia, O. Arancio and M. Shelanski, Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling, Proc Natl Acad Sci USA 99 (2002), 13217-13221.
30. D. Puzzo, O. Vitolo, F. Trinchese, J.P. Jacob, A. Palmeri and O. Arancio, amyloid-βpeptide inhibits activation of the nitric oxide/cGMP/cAMP- responsive element-binding protein pathway during hippocampal synaptic plasticity, J Neurosci 25 (2005), 6887-6897.
31. Q.L. Ma, M.E. Harris-White, O.J. Ubeda, M. Simmons, W. Beech, G.P. Lim, B. Teter, S.A. Frautschy and G.M. Cole, Evidence of Aβ- and transgene-dependent defects in ERKCREB signaling in Alzheimer's models, J Neurochem 103 (2007), 1594-1607.
32. 1-42 oligomers and upregulating synaptic plasticityrelated proteins in the hippocampus, Neuroscience (2009), in press, doi:10.1016/j. neuroscience.2009.07.014.
33. F.G. De Felice, A.P. Wasilewska-Sampaio, A.C. Barbosa, F.C. Gomes, W.L. Klein and S.T. Ferreira, Cyclic AMP enhancers and Aβ oligomerization blockers as potential therapeutic agents in Alzheimer's disease, Curr Alzheimer Res 4 (2007), 263-271.
34. R.A. Nixon, Autophagy, amyloidogenesis and Alzheimer disease, J Cell Sci 120 (2007), 4081-4091.
35. C.V. Garat, D. Fankell, P.F. Erickson, J.E. Reusch, N.N. Bauer, I.F. McMurtry and D.J. Klemm, Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells, Mol Cell Biol 26 (2006), 4934-4948.
36. S. Costes, B. Vandewalle, C. Tourrel-Cuzin, C. Broca, N. Linck, G. Bertrand, J. Kerr-Conte, B. Portha, F. Pattou, J. Bockaert and S. Dalle, Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets, Diabetes 58 (2009) 1105-1115.
37. K. Okamoto, S. Hirai, T. Iizuka, T. Yanagisawa and M.Watanabe, Reexamination of granulovacuolar degeneration, Acta Neuropathol 82 (1991), 340-345.
38. C. Stadelmann, T.L. Deckwerth, A. Srinivasan, C. Bancher,W. Brück, K. Jellinger and H. Lassmann, Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death, Am J Pathol 155 (1999), 1459-1466.
39. K. Leroy, A. Boutajangout, M. Authelet, J.R. Woodgett, B.H. Anderton and J.P. Brion, The active form of glycogen synthase kinase-3βis associated with granulovacuolar degeneration in neurons in Alzheimer's disease, Acta Neuropathol 103 (2002), 91-99.
40. S. Lagalwar, R.W. Berry and L.I. Binder, Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies, Acta Neuropathol 113 (2007), 63-73.
41. A. Thakur, X.Wang, S.L. Siedlak, G. Perry, M.A. Smith and X. Zhu, c-Jun phosphorylation in Alzheimer disease, J Neurosci Res 85 (2007), 1668-1673.
42. J.J. Hoozemans, E.S. van Haastert, D.A. Nijholt, A.J. Rozemuller, P. Eikelenboom and W. Scheper, The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus, Am J Pathol 174 (2009), 1241-1251.
43. A. Kadokura, T. Yamazaki, S. Kakuda, K. Makioka, C.A. Lemere, Y. Fujita, M. Takatama and K. Okamoto, Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration, Neurosci Lett (2009), in press, doi:10.1016/j.neulet.2009.06.024.
44. D.W. Dickson, H. Ksiezak-Reding, P. Davies and S.H. Yen, A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration, Acta Neuropathol 73 (1987), 254-258.
45. W. Bondareff, C.M.Wischik, M. Novak and M. Roth, Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease, Am J Pathol 139 (1991), 641-647.
46. B. Boland, A. Kumar, S. Lee, F.M. Platt, J. Wegiel, W.H. Yu and R.A. Nixon, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease, J Neurosci 28 (2008) 6926-6937.
47. W.Y. Ong, H.M. Lim, T.M. Lim and B. Lutz, Kainate-induced neuronal injury leads to persistent phosphorylation of cAMP response element-binding protein in glial and endothelial cells in the hippocampus, Exp Brain Res 131 (2000), 178-186.
48. L.J. Cox, U. Hengst, N.G. Gurskaya, K.A. Lukyanov and S.R. Jaffrey, Intra-axonal translation and retrograde trafficking of CREB promotes neuronal survival, Nat Cell Biol 10 (2008) 149-159.
49. I Granic, A.M. Dolga, I.M. Nijholt, G. van Dijk and U.L. Eisel, Inflammation and NF-κB in Alzheimer's disease and diabetes, J Alzheimers Dis 16 (2009), 809-821.
50. K. Terai, A. Matsuo and P.L. McGeer, Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer's disease, Brain Res 735 (1996), 159-168.
51. W.J. Lukiw, Y. Zhao and J.G. Cui, An NF-κB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells, J Biol Chem 283 (2008), 31315-31322.
52. D. Gezen-Ak, E. Dursun, T. Ertan, H. HanAβgasi, H. Gürvit, M. Emre, E. Eker, M. Oztürk, F. Engin and S. Yilmazer, Association between vitamin D receptor gene polymorphism and Alzheimer's disease, Tohoku J Exp Med 212 (2007), 275-282.
53. M.K. Sutherland, M.J. Somerville, L.K. Yoong, C. Bergeron, M.R. Haussler and D.R. McLachlan, Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels, Brain Res Mol Brain Res 13 (1992), 239-250.